Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from diabetes

The weight loss drug has been dubbed “Hollywood’s worst kept secret” and now it’s coming to the UK. So why does it all seem too good to be true?

Evening Standard

What to know about prescription drugs promising weight loss

WeightWatchers' acquisition of a telehealth company is just the latest commercial push into the market for a new generation of medications that promise significant weight loss

The Independent UK

Celebrity weight loss jab to be available on WeightWatchers

WeightWatchers has acquired telehealth provider Sequence that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Why diabetic women are more likely to have heart problems

Maryam Rahmani's research is just one small part of a larger effort to address the gender disparities that still exist in healthcare

Newsroom.co.nz

What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications

“Weight loss may turn back your biological age, but it tends to turn your facial clock forward,” one dermatologist says

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

The Independent UK

The cost of the Ozempic craze

The drug shortage is affecting people with Type 2 diabetes, and a surge in cosmetic use is to blame

Salon

Read news from The Economist, FT, and more,
with one subscription

Diabetes and obesity are on the rise in young adults, a study says

Young Black adults, Mexican Americans and other Hispanic adults experienced the greatest cardiovascular risk factors, according to a study published in the Journal of the American Medical Association.

WEKU

Yes, England’s new weight-loss drug kills your appetite – but as I know, it comes at a cost

While the medication I take has hugely helped my health, it has also robbed me of the joy I took in food, says critic Leila Latif

The Guardian - UK

Dear Abby: I’m worried friend is mishandling her diabetes and might die

Despite taking insulin, she has moments of becoming unresponsive.

Chicago Sun-Times

Eli Lilly is cutting insulin prices and capping copays at $35 – 5 questions answered

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70% and capping insulin copays at US$35 for uninsured patients and those with private health insurance. These changes follow efforts by the federal government, the California state government, nonprofits and some companies…

The Conversation

University of Dundee company MyWay helps Scottish Muslims fast during Ramadan

A UNIVERSITY of Dundee spinout company specialising in diabetes care is helping Muslims with the condition to fast safely during Ramadan.

The National (Scotland)

Charlotte Dawson praised for showing 'real' pregnancy life as she addresses fans' concern

Charlotte has been showing off her blossoming baby bump on social media

Manchester Evening News

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers

The cost of 14-year-old Freya Goldston's diabetes medication will soar next month when it's taken off the Pharmaceutical Benefits Scheme and her family don't know if they'll be able to afford it.

Tribune News Service

Eli Lilly is capping consumer insulin costs at $35

Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.

Al Jazeera

US drug maker to slash some insulin prices, expand cost cap

President Joe Biden hails move by Eli Lilly as a ‘big deal’, calling on other manufacturers to also reduce prices.

Chicago Sun-Times

Eli Lilly plans to slash prices of some older insulins, expand cost cap

Lawmakers and patient advocates have been pressuring drugmakers to take action on soaring drug prices.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Eli Lilly is capping customers’ insulin costs at $35

Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.

WEKU

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocket

The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.

Radio France Internationale

France steps up monitoring of diabetes drug used for weight loss

The French drug safety agency on Wednesday announced it was stepping up monitoring of Ozempic, a diabetes drug promoted by influencers on social networks who flaunt its weight-loss properties. As well as health concerns, the authorities say the increased demand could jeopardise access for legitimate diabetic patients.

The Independent UK

Lilly plans to slash some insulin prices, expand cost cap

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

Tribune News Service

How use of diabetes drug Ozempic for weight loss has led to a shortage: 'Let the diabetics have their drugs'

Ozempic has been catapulted into the public eye in recent months as celebrities and wellness influencers started taking it for weight loss. But Ozempic is a diabetes drug — and the craze has led to a shortage, leaving those who need it for Type 2 diabetes at a loss.

The Guardian - UK

German minister calls for ban on advertising junk food to children

Cem Özdemir said measure would help protect children from obesity and diabetes

1 … 67 68 69 70

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Sourn California

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.